Congressmen Boyle, Rutherford to Chair Lung Cancer Caucus
WASHINGTON, DC – Today, Congressman Brendan F. Boyle (PA-02) and Congressman John Rutherford (FL-04) are pleased to announce that they will serve as co-chairs of the bipartisan Congressional Lung Cancer Caucus for the 116th Congress. The group’s membership included 37 representatives from both sides of the aisle in the 115th Congress.
“A quarter million Americans are newly diagnosed with lung cancer each year, 80% of whom never smoked or quit over a decade ago. Yet, the incredible stigma of lung cancer remains, hurting research, treatment, and ultimately patient survival,” said Congressman Boyle. “As Co-Chair of the Lung Cancer Caucus, I am committed to breaking down this stigma, advocating for those affected by this cruel disease, and finally getting the resources we need to bring lung cancer to an end.”
“Serving as Co-Chair of the Lung Cancer Caucus provides an opportunity to advocate for greater awareness and the pursuit of solutions to end one of the most common cancers worldwide,” said Congressman Rutherford. “I have met many constituents whose lives have been affected by this terrible disease and seen firsthand how important it is to find an end to lung cancer. I am honored to help lead this critical effort and look forward to achieving meaningful legislative successes to reduce the impact of lung cancer in 2019 and beyond.”
“We are thrilled to maintain this important platform in the new Congress to continue to raise awareness and educate Members and staff on issues of lung cancer early detection and research needs,” said Laurie Fenton Ambrose, President & CEO of Lung Cancer Alliance. “Thank you Congressman Boyle and Congressman Rutherford for being our Caucus Co-Chairs and champions as we move forward in the 116th Congress.”
Lung cancer is the second most common cancer and is a leading cause of death in the United States. Each year more people die of lung cancer than colon, breast, and prostate cancer combined. The Lung Cancer Caucus helps educate and inform Members of Congress on issues specifically related to eliminating the stigma, reducing mortality, improving survivorship, furthering research, and ensuring equitable access to preventive screening, treatments, diagnostics and testing of lung cancer.